Meekang Sung, Vaughan W Rees, Hannah Lee, Mohammad S Jalali
{"title":"评估南韩药物使用研究中的流行病学数据和监测:洞察力与未来方向》。","authors":"Meekang Sung, Vaughan W Rees, Hannah Lee, Mohammad S Jalali","doi":"10.3961/jpmph.24.171","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Effective data collection and surveillance of epidemiological trends are essential in confronting the growing challenges associated with substance use (SU), especially in light of emerging trends and underreporting of cases. However, research and data are scarce regarding SU and substance use disorder (SUD) in Korea.</p><p><strong>Methods: </strong>We conducted a scoping review to identify data sources and surveillance methods used in SU research in Korea up to December 2023. This review was complemented by semi-structured consultations with experts in this area in Korea, whose feedback led to revisions of previously identified data sources and assessments.</p><p><strong>Results: </strong>Our review identified 32 publications conducting secondary analyses on existing data to examine the epidemiology of SU and SUD in Korea. Of these, 14 studies utilized clinical databases to explore the prescription patterns of addictive substances, particularly opioids. Eleven data sources showed promise for advancing SU research; however, they face substantial limitations, including a lack of available data, missing data, the absence of key variables, the exclusion of marginalized populations not captured within the clinical system, and complexities in matching individual-level data across time points and datasets.</p><p><strong>Conclusions: </strong>Current surveillance methods for SU in Korea face considerable challenges in accessibility, usability, and standardization. Moreover, existing data repositories may fail to capture information on populations not served by clinical or judicial systems. To systematically improve surveillance approaches, it is necessary to develop a robust and nationally representative survey, refine the use of existing clinical data, and ensure the availability of data on treatment facilities.</p>","PeriodicalId":16893,"journal":{"name":"Journal of Preventive Medicine and Public Health","volume":" ","pages":"307-318"},"PeriodicalIF":2.8000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11309831/pdf/","citationCount":"0","resultStr":"{\"title\":\"Assessment of Epidemiological Data and Surveillance in Korea Substance Use Research: Insights and Future Directions.\",\"authors\":\"Meekang Sung, Vaughan W Rees, Hannah Lee, Mohammad S Jalali\",\"doi\":\"10.3961/jpmph.24.171\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>Effective data collection and surveillance of epidemiological trends are essential in confronting the growing challenges associated with substance use (SU), especially in light of emerging trends and underreporting of cases. However, research and data are scarce regarding SU and substance use disorder (SUD) in Korea.</p><p><strong>Methods: </strong>We conducted a scoping review to identify data sources and surveillance methods used in SU research in Korea up to December 2023. This review was complemented by semi-structured consultations with experts in this area in Korea, whose feedback led to revisions of previously identified data sources and assessments.</p><p><strong>Results: </strong>Our review identified 32 publications conducting secondary analyses on existing data to examine the epidemiology of SU and SUD in Korea. Of these, 14 studies utilized clinical databases to explore the prescription patterns of addictive substances, particularly opioids. Eleven data sources showed promise for advancing SU research; however, they face substantial limitations, including a lack of available data, missing data, the absence of key variables, the exclusion of marginalized populations not captured within the clinical system, and complexities in matching individual-level data across time points and datasets.</p><p><strong>Conclusions: </strong>Current surveillance methods for SU in Korea face considerable challenges in accessibility, usability, and standardization. Moreover, existing data repositories may fail to capture information on populations not served by clinical or judicial systems. To systematically improve surveillance approaches, it is necessary to develop a robust and nationally representative survey, refine the use of existing clinical data, and ensure the availability of data on treatment facilities.</p>\",\"PeriodicalId\":16893,\"journal\":{\"name\":\"Journal of Preventive Medicine and Public Health\",\"volume\":\" \",\"pages\":\"307-318\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2024-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11309831/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Preventive Medicine and Public Health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3961/jpmph.24.171\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/6/24 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Preventive Medicine and Public Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3961/jpmph.24.171","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/24 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0
摘要
目标:有效的数据收集和流行病趋势监测对于应对与药物使用(SU)相关的日益严峻的挑战至关重要,特别是考虑到新出现的趋势和病例报告不足的情况。然而,有关韩国药物滥用和药物使用障碍(SUD)的研究和数据却很少:我们进行了一次范围审查,以确定截至 2023 年 12 月韩国 SU 研究中使用的数据来源和监测方法。此外,我们还与韩国该领域的专家进行了半结构式咨询,专家们的反馈意见促使我们对之前确定的数据来源和评估方法进行了修订:我们的研究发现了 32 篇对现有数据进行二次分析以研究韩国 SU 和 SUD 流行病学的出版物。其中,14 项研究利用临床数据库探索了成瘾物质(尤其是阿片类药物)的处方模式。有 11 个数据源显示出了推进 SU 研究的前景;然而,这些数据源也面临着很大的局限性,包括缺乏可用数据、数据缺失、关键变量缺失、排除了临床系统中未涵盖的边缘化人群,以及跨时间点和数据集匹配个体水平数据的复杂性:韩国目前的 SU 监测方法在可访问性、可用性和标准化方面面临着相当大的挑战。此外,现有的数据存储库可能无法捕捉到非临床或司法系统服务人群的信息。为了系统地改进监测方法,有必要开展一项具有全国代表性的有力调查,完善现有临床数据的使用,并确保治疗机构数据的可用性。
Assessment of Epidemiological Data and Surveillance in Korea Substance Use Research: Insights and Future Directions.
Objectives: Effective data collection and surveillance of epidemiological trends are essential in confronting the growing challenges associated with substance use (SU), especially in light of emerging trends and underreporting of cases. However, research and data are scarce regarding SU and substance use disorder (SUD) in Korea.
Methods: We conducted a scoping review to identify data sources and surveillance methods used in SU research in Korea up to December 2023. This review was complemented by semi-structured consultations with experts in this area in Korea, whose feedback led to revisions of previously identified data sources and assessments.
Results: Our review identified 32 publications conducting secondary analyses on existing data to examine the epidemiology of SU and SUD in Korea. Of these, 14 studies utilized clinical databases to explore the prescription patterns of addictive substances, particularly opioids. Eleven data sources showed promise for advancing SU research; however, they face substantial limitations, including a lack of available data, missing data, the absence of key variables, the exclusion of marginalized populations not captured within the clinical system, and complexities in matching individual-level data across time points and datasets.
Conclusions: Current surveillance methods for SU in Korea face considerable challenges in accessibility, usability, and standardization. Moreover, existing data repositories may fail to capture information on populations not served by clinical or judicial systems. To systematically improve surveillance approaches, it is necessary to develop a robust and nationally representative survey, refine the use of existing clinical data, and ensure the availability of data on treatment facilities.